Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia Pharmaceutical Investing
Universal Ibogaine to Participate in the 2022 Virtual Growth Conference - Presented by Maxim Group LLC and hosted by M-Vest on March 28th - 30th from 9:00 a.m. - 5:00 p.m. EDT Pharmaceutical Investing
COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK Psychedelics Investing
NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga Psychedelics Investing
NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects Psychedelics Investing
UNIVERSAL IBOGAINE EXPANDS RESEARCH TEAM WITH JULIE DUMOUCHEL, DIRECTOR OF CLINICAL TRIALS Pharmaceutical Investing
